Ascendis Health Limited provided earnings guidance for the six months ended 31 December 2023. For the period, the company expected continuing Operations: earnings per share from continuing operations will be between 9.2 cents and 11.2 cents, compared to the loss per share from continuing operations of 29.4 cents reported for the prior corresponding period. Total Operations: earnings per share will be between 11.4 cents and 14.0 cents, representing a decrease of
between 64.8% and 56.9% compared to the earnings per share from total operations of 32.5
cents reported for the prior corresponding period.